학술논문

Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection.
Document Type
Article
Source
Hepatology (02709139); Jul2020, Vol. 72 Issue 1, p7-18, 12p
Subject
Language
ISSN
02709139